Halia Therapeutics is a biopharmaceutical company manufacturing therapies to improve the lives of patients with inflammatory disorders.
Halia Therapeutics has raised $337K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Halia Therapeutics's investors include Todd Pedersen.
Halia Therapeutics is headquartered in Lehi, United States.
Halia Therapeutics is a biopharmaceutical company manufacturing therapies to improve the lives of patients with inflammatory disorders.
Halia Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Halia Therapeutics — Funding & Investors." VCBacked, July 16, 2025, https://www.vcbacked.co/company/halia-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Halia Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/halia-therapeutics
{{cite web |title=Halia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/halia-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated